Unknown

Dataset Information

0

Effect of Continuous Positive Airway Pressure on Blood Pressure Variability in Patients With Obstructive Sleep Apnea.


ABSTRACT: Obstructive sleep apnea (OSA) is a common risk factor for cardiovascular disease. Continuous positive airway pressure (CPAP) improves OSA symptoms and blood pressure (BP) control. The effect of CPAP on BP variability (BPV) in patients with and without hypertension treated with autotitrating CPAP (APAP) for 2 weeks was studied. A total of 78 participants (76.9% men, 49% hypertensive, mean body mass index 36.2 [6.9] kg/m2 , age 49.0 [12.9] years) underwent 2 weeks of APAP therapy. Office BP, BPV (standard deviation of three BP measurements), and pulse rate were measured before and after treatment. Systolic BPV (5.3±4.9 vs 4.2±3.4 mm Hg, P=.047) and pulse rate (78.0±14.5 vs 75.5±15.8 beats per minute, P=.032) decreased after treatment, particularly in hypertensive participants. Mask leak was independently associated with reduced changes in systolic BPV (r=-0.237, P=.048). Short-term APAP treatment reduced BPV and pulse rate, particularly in hypertensive patients with OSA.

SUBMITTER: Pengo MF 

PROVIDER: S-EPMC8031566 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of Continuous Positive Airway Pressure on Blood Pressure Variability in Patients With Obstructive Sleep Apnea.

Pengo Martino F MF   Ratneswaran Culadeeban C   Berry Marc M   Kent Brian D BD   Kohler Malcolm M   Rossi Gian Paolo GP   Steier Joerg J  

Journal of clinical hypertension (Greenwich, Conn.) 20160601 11


Obstructive sleep apnea (OSA) is a common risk factor for cardiovascular disease. Continuous positive airway pressure (CPAP) improves OSA symptoms and blood pressure (BP) control. The effect of CPAP on BP variability (BPV) in patients with and without hypertension treated with autotitrating CPAP (APAP) for 2 weeks was studied. A total of 78 participants (76.9% men, 49% hypertensive, mean body mass index 36.2 [6.9] kg/m<sup>2</sup> , age 49.0 [12.9] years) underwent 2 weeks of APAP therapy. Offic  ...[more]

Similar Datasets

| S-EPMC7956605 | biostudies-literature
| S-EPMC6353003 | biostudies-literature
| S-EPMC11009577 | biostudies-literature
| S-EPMC5412857 | biostudies-literature
| S-EPMC2718445 | biostudies-literature
| S-EPMC8314910 | biostudies-literature
| S-EPMC2809244 | biostudies-literature
| S-EPMC8837151 | biostudies-literature
| S-EPMC10472589 | biostudies-literature
| S-EPMC4569056 | biostudies-literature